KR19980026245A - Diet Nutritional Composition - Google Patents
Diet Nutritional Composition Download PDFInfo
- Publication number
- KR19980026245A KR19980026245A KR1019960044612A KR19960044612A KR19980026245A KR 19980026245 A KR19980026245 A KR 19980026245A KR 1019960044612 A KR1019960044612 A KR 1019960044612A KR 19960044612 A KR19960044612 A KR 19960044612A KR 19980026245 A KR19980026245 A KR 19980026245A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- vitamin
- protein
- diet
- nutritional composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 43
- 235000005911 diet Nutrition 0.000 title claims abstract description 41
- 230000037213 diet Effects 0.000 title claims abstract description 37
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 claims abstract description 50
- 235000018102 proteins Nutrition 0.000 claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 27
- 235000021329 brown rice Nutrition 0.000 claims abstract description 27
- 244000068988 Glycine max Species 0.000 claims abstract description 26
- 229960002666 1-octacosanol Drugs 0.000 claims abstract description 25
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 23
- 239000011707 mineral Substances 0.000 claims abstract description 23
- 235000013336 milk Nutrition 0.000 claims abstract description 22
- 239000008267 milk Substances 0.000 claims abstract description 22
- 210000004080 milk Anatomy 0.000 claims abstract description 22
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 21
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 20
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 15
- 102000030202 Dietary Animal Proteins Human genes 0.000 claims abstract description 8
- 108091004234 Dietary Animal Proteins Proteins 0.000 claims abstract description 8
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims abstract description 8
- 230000035764 nutrition Effects 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims description 46
- 230000004580 weight loss Effects 0.000 abstract description 28
- 230000037323 metabolic rate Effects 0.000 abstract description 27
- 210000000577 adipose tissue Anatomy 0.000 abstract description 25
- 235000019629 palatability Nutrition 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 13
- 230000002195 synergetic effect Effects 0.000 abstract description 11
- 235000001916 dieting Nutrition 0.000 abstract description 4
- 230000037228 dieting effect Effects 0.000 abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 22
- 235000010755 mineral Nutrition 0.000 description 21
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 20
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 20
- 108010073771 Soybean Proteins Proteins 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 229940001941 soy protein Drugs 0.000 description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 102000014171 Milk Proteins Human genes 0.000 description 12
- 108010011756 Milk Proteins Proteins 0.000 description 12
- 235000021239 milk protein Nutrition 0.000 description 12
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 11
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 11
- 229920000926 Galactomannan Polymers 0.000 description 11
- 229920002581 Glucomannan Polymers 0.000 description 11
- 208000008589 Obesity Diseases 0.000 description 11
- 229930003427 Vitamin E Natural products 0.000 description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 11
- 229940046240 glucomannan Drugs 0.000 description 11
- 235000020824 obesity Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 235000019165 vitamin E Nutrition 0.000 description 11
- 229940046009 vitamin E Drugs 0.000 description 11
- 239000011709 vitamin E Substances 0.000 description 11
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 10
- 229930091371 Fructose Natural products 0.000 description 10
- 239000005715 Fructose Substances 0.000 description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 10
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 10
- 229930003268 Vitamin C Natural products 0.000 description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 10
- 229960002685 biotin Drugs 0.000 description 10
- 235000020958 biotin Nutrition 0.000 description 10
- 239000011616 biotin Substances 0.000 description 10
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 10
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 10
- 229960000304 folic acid Drugs 0.000 description 10
- 235000019152 folic acid Nutrition 0.000 description 10
- 239000011724 folic acid Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 229960003966 nicotinamide Drugs 0.000 description 10
- 235000005152 nicotinamide Nutrition 0.000 description 10
- 239000011570 nicotinamide Substances 0.000 description 10
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 10
- 235000019155 vitamin A Nutrition 0.000 description 10
- 239000011719 vitamin A Substances 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 10
- 229940045997 vitamin a Drugs 0.000 description 10
- 244000000626 Daucus carota Species 0.000 description 9
- 235000002767 Daucus carota Nutrition 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 8
- 239000004375 Dextrin Substances 0.000 description 7
- 229920001353 Dextrin Polymers 0.000 description 7
- 235000019425 dextrin Nutrition 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 5
- 240000006891 Artemisia vulgaris Species 0.000 description 5
- 238000009534 blood test Methods 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000009535 clinical urine test Methods 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- -1 propylene glycol fatty acid ester Chemical class 0.000 description 5
- 240000008067 Cucumis sativus Species 0.000 description 4
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 4
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical compound CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229940089491 hydroxycitric acid Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 206010014733 Endometrial cancer Diseases 0.000 description 2
- 206010014759 Endometrial neoplasm Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000009164 Petroselinum crispum Species 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000002468 fat body Anatomy 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 101000856500 Bacillus subtilis subsp. natto Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 241000593508 Garcinia Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002777 columnar cell Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000005523 excessive nutrition Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000021486 meal replacement product Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 229960003226 nikethamide Drugs 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 체중 감량효과와 함께 기호성을 더욱 개선시킨 다이어트 영양조성물에 관한 것으로, 더욱 상세하게는 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄 및 각종 비타민을 배합한 영양조성물에, 대두분리단백펩타이드 또는 가르시니아 캄보지아 추출물 중에서 선택된 1종 이상과, 현미 및 옥타코사놀을 배합함으로써, 기호성이 좋고, 체중감량 외에 체지방 감소에 있어서 상승효과를 얻을 수 있으며, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어지도록 하는 다이어트 영양조성물에 관한 것이다.The present invention relates to a diet nutritional composition that further improves palatability with weight loss effect, and more specifically, soybean separation in a nutritional composition containing vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins. By combining one or more selected from protein peptides or garcinia cambogia extract with brown rice and octacosanol, palatability is good, synergistic effect can be obtained in body fat reduction in addition to weight loss, and weight loss at the level where the basic metabolic rate does not drop during dieting It relates to a diet nutrition composition to be made.
Description
본 발명은 체중 감량효과와 함께 기호성을 더욱 개선시킨 다이어트 영양조성물에 관한 것으로, 더욱 상세하게는 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄 및 각종 비타민을 배합한 영양조성물에, 대두분리단백펩타이드 또는 가르시니아 캄보지아 추출물 중에서 선택된 1종 이상과, 현미 및 옥타코사놀을 배합함으로써, 기호성이 좋고, 체중감량 외에 체지방 감소에 있어서 상승효과를 얻을 수 있으며, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어지도록 하는 다이어트 영양조성물에 관한 것이다.The present invention relates to a diet nutritional composition that further improves palatability with weight loss effect, and more specifically, soybean separation in a nutritional composition containing vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins. By combining one or more selected from protein peptides or garcinia cambogia extract with brown rice and octacosanol, palatability is good, synergistic effect can be obtained in body fat reduction in addition to weight loss, and weight loss at the level where the basic metabolic rate does not drop during dieting It relates to a diet nutrition composition to be made.
현대에 들어와서 영양 섭취상태가 양호해지면서 사람들의 체격이 향상되는 효과를 거두었다. 그러나, 영양의 과잉 섭취와 생활환경의 변화에 따른 운동 부족등으로 비만자가 급격히 늘어나는 부작용도 함께 나타났다.In modern times, nutrition has been improved and people's physique has been improved. However, the side effect of obesity increased rapidly due to excessive nutrition and lack of exercise due to changes in living environment.
비만은 임상적으로 각종 질병의 발생에 관여하거나 질병을 악화시킨다. 비만과 관련된 질병으로서는 고혈압, 동맥경화, 당뇨, 지방간 및 담석증, 통풍 등이 있다. 특히 여성에게는 자궁내막암, 담낭암, 자궁경부암, 난소암, 유방암 등이 더 흔히 발생하고, 자궁내막암의 경우 비만증에 의한 발병 및 사망률의 증가가 다른 암질환에 비해 가장 현저한 것으로 보고되어 있다. 또한 사망률에 있어서도 비만자는 정상 체중자들 보다 1.3배 이상 더 높은 것으로 보고되어 있다.Obesity is clinically involved in, or worsens, the development of various diseases. Obesity-related diseases include high blood pressure, arteriosclerosis, diabetes, fatty liver and cholelithiasis, and gout. Particularly, endometrial cancer, gallbladder cancer, cervical cancer, ovarian cancer, and breast cancer are more common in women, and in the case of endometrial cancer, the incidence and mortality increase due to obesity have been reported to be most significant compared to other cancer diseases. It is also reported that obesity is more than 1.3 times higher than normal weight in mortality.
그러므로, 비만은 미리 예방하는 것이 필요하고, 비만증으로 된 경우에는 빨리 체중감량을 통하여 정상체중으로 만들어 원활한 신진 대사가 이루어지도록 하는 것이 중요하다.Therefore, it is necessary to prevent obesity in advance, and if it becomes obesity, it is important to make a normal metabolism through weight loss as soon as possible to achieve a smooth metabolism.
비만자들이 체중감량에 기울이는 관심과 노력이 높다는 점을 이용하여 사과 다이어트, 포도 다이어트, 요쿠르트 다이어트, 토닝 시스템, 원적외선사우나복 등 여러 가지 다이어트법들이 소개되고 있고, 또 시중에 다이어트를 위한 제품들이 많이 등장하고 있다. 특히 시중의 식사대용식 다이어트 제품들이 요즘 주목되고 있다.Taking advantage of the high interest and effort of obese people to lose weight, various diets such as apple diet, grape diet, yogurt diet, toning system, and far infrared sauna clothes are introduced, and many products for diet appear in the market. Doing. In particular, meal replacement diet products on the market are attracting attention these days.
그러나, 이러한 식사대용식 제품들이 어느 정도 체중감량 효과가 있기는 하지만 실제 그 효과가 미미하고, 영양의 불균형으로 인하여 신체에 상당한 무리를 주기 쉽다. 구체적으로, 신체에 필수적인 영양소들을 제대로 공급시켜 주지 못하며, 식사량이 감소됨으로써 장의 기능이 떨어지게 되고, 비타민, 미네랄의 공급이 불충분해지기 때문에 신진대사가 정상적으로 이루어지지 못하며, 체중감량이 체지방의 감소로 이루어져야 함에도 불구하고 체지방보다는 근육, 뼈, 장기 등의 제지방이 많이 감소됨으로써 오히려 신체에 무리를 주는 문제점이 있다. 더욱이 체중감소와 더불어 기초대사율도 급속하게 감소되는데, 이 경우 감소된 기초대사율 만큼의 칼로리 여분이 지방으로 바뀌게 되어 다이어트 하기 전보다 체중이 더 증가하는 요요현상이 발생하기도 한다.However, although these meal replacement products have some weight loss effect, the effect is insignificant, and due to nutritional imbalance, it is easy to put a considerable burden on the body. Specifically, the essential nutrients to the body can not be properly supplied, the amount of meal is reduced, the intestinal function is reduced, the supply of vitamins and minerals is insufficient, metabolism is not normal, weight loss should be made of reduced body fat Nevertheless, rather than body fat, muscles, bones, organs, etc. are reduced a lot of fat is rather a problem giving the body. In addition to the weight loss, the basic metabolic rate decreases rapidly, and in this case, the reduced caloric excess is converted into fat, which leads to a yo-yo phenomenon in which the weight is increased more than before the diet.
이에, 본 발명자들은 체중감량과 관련된 제 문제점을 갖지 않으면서 효과적으로 체중감량 효과를 나타낼 수 있는 영양 다이어트 조성물을 제공하고자 광범위하게 연구하였으며, 그 결과 1995년 6월 17일자로 다이어트 영양조성물을 발명의 명칭으로 하여, 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄 및 각종 비타민을 배합한 영양조성물에, 생약재 엑기스 건조분말과 콜라겐의 혼합물을 첨가하여 이루어진 것으로, 체중감량 외에 체지방 감소, 기초대사율의 유지, 혈액개선 등에 상승효과를 나타내는 다이어트 영양조성물에 관하여 출원한 바 있다.Accordingly, the present inventors studied extensively to provide a nutritional diet composition that can effectively exhibit a weight loss effect without having problems related to weight loss, and as a result, the diet nutrition composition as of June 17, 1995 was named. It is made by adding a mixture of herbal extract extract powder and collagen to nutritional composition containing vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins. It has been filed for a diet nutritional composition showing synergistic effect on fats and oils, blood improvement, and the like.
그러나, 기출원된 조성물의 경우 체지방 감소에 있어서 상승효과를 목적으로 생약재 엑기스 건조분말을 혼용함으로써, 생약재 고유의 이미, 이취에 의해 기호성이 떨어지는 문제점을 갖고 있으며, 인공적인 향으로 맛을 내는 경우 쉽게 질리는 경향이 있어, 질리지 않으면서 기호성을 증강시키는 것이 크게 요망되어 왔다.However, in the case of the previously filed composition, by mixing the herbal extract extract powder for the purpose of synergistic effect in reducing body fat, the herb has already had a problem of poor palatability by off-flavor, and when flavored with artificial fragrance, There is a tendency to get tired, and it has been greatly desired to enhance palatability without getting tired.
이에, 본 발명자들은, 고유의 이미, 이취가 강한 생약재 대신, 대두분리단백펩타이드 또는 가르시니아 캄보지아 추출물을 배합하고, 여기에 현미와 옥타코사놀을 배합함으로써, 체지방 감소에 있어서 상승효과를 얻을 수 있으면서, 향과 맛의 기호성이 우수하며, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어지도록 할 수 있음을 알고 본 발명을 완성하게 되었다.Thus, the present inventors, instead of the original medicinal herbs with strong odor, by combining soybean isolate protein peptide or garcinia cambogia extract, and by combining brown rice and octacosanol, synergistic effect can be obtained in reducing body fat, The taste of the taste is excellent, the weight of the basic metabolic rate during diet can be achieved so that the weight loss can be made to complete the present invention.
따라서, 본 발명의 목적은 향과 맛의 기호성이 우수하면서도 효과적인 체중감량효과를 나타내고 신체의 제 기능을 유지 또는 개선시킬 수 있는 다이어트 영양조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a diet nutrition composition that exhibits excellent palatability of flavor and taste while showing an effective weight loss effect and maintaining or improving the function of the body.
상기한 목적은, 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄 및 각종 비타민을 배합한 영양조성물에, 대두분리단백펩타이드 또는 가르시니아 캄보지아 추출물 중에서 선택된 1종 이상과, 현미 및 옥타코사놀을 배합하여 이루어진 영양조성물에 의해 달성될 수 있으며, 본 발명에 따른 다이어트 영양조성물은 기호성이 우수하며, 체중감량 외에 체지방 감소에 있어서 상승효과를 제공할 수 있고, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어지도록 할 수 있다.The above object is a combination of vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins, at least one selected from soybean isolate protein or Garcinia cambogia extract, and brown rice and octacosanol It can be achieved by the nutrition composition, the diet nutrition composition according to the present invention is excellent in palatability, can provide a synergistic effect in reducing body fat in addition to weight loss, weight loss at a level that does not fall the basic metabolic rate during diet Can be done.
본 발명의 다른 목적, 특징 및 적용은 하기 발명의 상세한 설명란으로부터 당업자에게 명백하게 드러날 것이다.Other objects, features and applications of the present invention will become apparent to those skilled in the art from the following detailed description.
본 발명에 따른 다이어트 영양조성물은, 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄 및 각종 비타민을 배합한 영양조성물에, 대두분리단백펩타이드 또는 가르시니아 캄보지아 추출물 중에서 선택된 1종 이상과, 현미 및 옥타코사놀을 배합하여 이루어지는 것을 특징으로 하며, 체중감량, 기초대사율유지, 체지방 감량 등의 다이어트 효과와 혈액검사, 소변검사 등을 통해 신체 각 기능의 유지 또는 개선효과가 있을 뿐만 아니라 맛과 향의 기호성에서도 우수하다.Dietary nutritional composition according to the present invention, at least one selected from soybean isolate protein peptide or garcinia cambogia extract, to the nutritional composition containing vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins, brown rice and It is characterized by consisting of octacosanol, weight loss, maintenance of basic metabolic rate, body fat loss, diet, blood test, urine test, etc. to maintain or improve the function of each body, as well as taste and flavor great.
본 발명에서 사용되는 다이어트 영양조성물의 주요 원료에 관하여 설명한다.The main raw materials of the diet nutritional composition used in the present invention will be described.
본 발명에서 사용된 식물성 대두단백은 콩(Glycine maxMerill)에서 추출 분리한 단백으로서, 필수아미노산이 풍부하게 함유되어 있는 완전단백이다. 대두단백은 콜레스테롤 강하효과, 발암 억제효과 등이 확인되고 있다. 본 발명에서 사용하는 대두단백은 단백질 함량이 80중량% 이상인 것을 사용하지만, 단백질 함량이 이러한 경우에만 한정되는 것은 아니다. 이러한 식물성 대두단백은 15~55중량%의 양으로 배합되는 것이 바람직하다. 15중량% 미만일 경우 단백질의 공급이 부족할 염려가 있고, 55중량%를 초과할 경우 다른 영양성분의 보강이 불충분하게 될 수 있다.Vegetable soy protein used in the present invention is a protein extracted from soybean ( Glycine max Merill), is a complete protein rich in essential amino acids. Soy protein has been shown to lower cholesterol and inhibit carcinogenesis. The soy protein used in the present invention uses a protein content of 80% by weight or more, but the protein content is not limited thereto. Such vegetable soy protein is preferably blended in an amount of 15 to 55% by weight. If it is less than 15% by weight, there is a concern that the supply of protein is insufficient, and if it exceeds 55% by weight, the reinforcement of other nutrients may be insufficient.
동물성 단백은 우유 또는 계란에서 추출 분리한 단백으로서, 유단백(Milk protein) 또는 난단백(Egg white protein)을 말하며, 카제인 또는 알부민이 풍부하게 함유되어 있고, 필수아미노산이 풍부하게 함유되어 있다. 본 발명에서 사용하는 유단백 또는 난단백은 단백질 함량이 80중량% 이상의 것을 사용하지만, 단백질 함량이 이러한 경우에만 한정되는 것은 아니다. 이러한 동물성 단백은 8~40중량%의 양으로 배합되는 것이 바람직하다. 8중량% 미만일 경우 단백질의 공급이 부족할 염려가 있고, 40중량%를 초과할 경우 다른 영양성분의 보강이 불충분하게 될 수 있다.Animal protein is a protein extracted from milk or egg, and refers to milk protein or egg white protein. It is rich in casein or albumin and rich in essential amino acids. The milk protein or egg protein used in the present invention uses a protein content of 80% by weight or more, but the protein content is not limited only to this case. Such animal protein is preferably blended in an amount of 8 to 40% by weight. If it is less than 8% by weight, there is a concern that the supply of protein is insufficient, and if it exceeds 40% by weight, the reinforcement of other nutrients may be insufficient.
식이섬유는 변량을 증가시키며, 혈중 콜레스테롤을 낮춘다. 본 발명에서는 식이섬유로서 대두식이섬유, 옥수수식이섬유, 갈락토만난, 글루코만난, 차전자피 등의 수용성 또는 불용성 식이섬유를 사용할 수 있다. 본 발명의 조성물에서 식이섬유는 10~30중량%의 양으로 배합되는 것이 바람직하다. 10중량% 미만일 경우 식이섬유의 첨가효과가 불충분하며, 30중량%를 초과할 경우 점성이 증가하게 되므로 복용에 불편하다.Dietary fiber increases variance and lowers blood cholesterol. In the present invention, water-soluble or insoluble dietary fiber, such as soy dietary fiber, corn dietary fiber, galactomannan, glucomannan, chaff bark, can be used as the dietary fiber. In the composition of the present invention, the dietary fiber is preferably blended in an amount of 10 to 30% by weight. If less than 10% by weight of the addition effect of dietary fiber is insufficient, if it exceeds 30% by weight will increase the viscosity is inconvenient to take.
올리고당은 이소말토스, 이소말토트리오스 및 판노스 등이 많이 함유된 이소말토올리고당, 프락토올리고당, 갈락토올리고당으로서 비피더스균의 증식인자이며 변비개선 효과가 있기도 하다. 본 발명의 조성물에서 올리고당은 1~10중량%의 양으로 배합되는 것이 바람직하다. 1중량% 미만일 경우 올리고당의 첨가효과가 없으며, 10중량%를 초과할 경우 기호성이 떨어진다.Oligosaccharides are isomaltoligosaccharides, fructooligosaccharides, and galactooligosaccharides containing a lot of isomaltose, isomaltotriose and pannose, and are a growth factor of bifidus bacterium and are also effective in improving constipation. In the composition of the present invention, the oligosaccharide is preferably blended in an amount of 1 to 10% by weight. If it is less than 1% by weight, there is no effect of adding oligosaccharide, and if it exceeds 10% by weight, palatability is inferior.
천연 우유미네랄은 우유에서 추출하여 정제한 미네랄로서, 칼슘을 비롯한 각종 무기질이 풍부하게 함유되어 있다. 본 발명의 조성물에서 천연 우유미네랄은 1~5중량%의 양으로 배합되는 것이 바람직하다. 1중량% 미만일 경우 첨가효과가 없으며, 5중량%를 초과할 경우 기호성이 떨어진다.Natural milk mineral is a mineral extracted from milk and rich in various minerals including calcium. In the composition of the present invention, natural milk mineral is preferably blended in an amount of 1 to 5% by weight. If it is less than 1% by weight, there is no additive effect, and if it exceeds 5% by weight, palatability is inferior.
각종 비타민류는 일일 권장량을 기준으로 하여 적절하게 증감하여 첨가하도록 한다.Various vitamins should be added and added appropriately based on the daily recommended amount.
또한, 본 발명에 따른 다이어트 영양조성물의 다이어트 상승효과와, 기호성 및 기초대사율 유지를 목적으로 배합하여 사용하는 원료에 대하여 설명한다.In addition, the dietary synergistic effect of the dietary nutritional composition according to the present invention, and raw materials used in combination for the purpose of maintaining palatability and basic metabolic rate will be described.
본 발명에서는 체중감량 외에 체지방 감소에 있어서의 상승효과를 목적으로, 대두분리단백펩타이드 분말 또는 가르시니아 캄보지아 추출물을 배합하고 있다. 이들 원료는 지방대사를 촉진시키거나, 잉여 당질이 지방으로 변환되는 과정을 차단함으로써 체지방을 감소시키는 작용을 갖고 있다.In the present invention, soybean isolated protein peptide powder or garcinia cambogia extract is formulated for the synergistic effect in reducing body fat in addition to weight loss. These raw materials have a function of reducing body fat by promoting fat metabolism or blocking the conversion of excess sugar into fat.
대두분리단백펩타이드 분말은 대두에서 분리한 단백질을 생화학적 효소로 처리함으로써 얻어지는, 평균 펩타이드 길이가 3~8개인 올리고펩타이드로서, 변비완화작용, 혈중 콜레스테롤치가 정상으로 되는 작용, 뇌혈관질환 및 심장병의 증상을 완화하는 작용 등이 알려져 있다. 이러한 대두분리단백펩타이드 분말은 0.1~10중량%의 양으로 배합되는 것이 바람직하다. 0.1중량% 미만일 경우 첨가효과가 없으며, 10중량%를 초과할 경우 기호성이 줄어들게 된다.Soybean isolated protein peptides are oligopeptides with an average peptide length of 3 to 8 obtained by treating proteins isolated from soybeans with biochemical enzymes, and are used for constipation relief, normalization of blood cholesterol levels, cerebrovascular disease and heart disease. It is known to alleviate the symptoms. Such soybean isolate protein powder is preferably formulated in an amount of 0.1 to 10% by weight. If it is less than 0.1% by weight, there is no additive effect, and if it exceeds 10% by weight, the palatability is reduced.
가르시니아 캄보지아 추출물은가르시니아 캄보지아열매의 과피를 추출하여 분말화한 것으로, HCA(Hydroxy Citric Acid)를 함유하고 있다. HCA는 구연산에 비해 ATP구연산리아제와의 결합력이 100배 이상 강하여, 그 결과 잉여 당질이 지방으로 변환되는 과정을 차단하는 역할을 한다. 이로 인해 지방산과 콜레스레롤의 생성이 감소되고 해당경로가 늦추어지고 글리코겐이 증가하게 된다. 이러한 가르시니아 캄보지아 추출물은 0.1~10중량%의 양으로 배합되는 것이 바람직하다. 0.1중량% 미만일 경우 첨가효과가 없으며, 10중량%를 초과할 경우 특유의 맛으로 인해 기호성이 줄어들게 된다.Garcinia cambogia extract is powdered by extracting the rinds of garcinia cambogia fruit, and contains HCA (Hydroxy Citric Acid). HCA is more than 100 times stronger than citric acid in binding to ATP citric acid, resulting in blocking the process of conversion of excess sugar into fat. This reduces the production of fatty acids and cholesterol, slows the pathway and increases glycogen. Such Garcinia cambogia extract is preferably blended in an amount of 0.1 to 10% by weight. If it is less than 0.1% by weight, there is no additive effect, and if it exceeds 10% by weight, the palatability is reduced due to its unique taste.
본 발명에 따른 영양조성물에서는 기호성의 개선을 위하여 조성물에 현미를 배합하는 것을 특징으로 한다. 현미는 수확한 벼로부터 제일 바깥쪽의 왕겨만을 벗긴 것으로 비타민 B1, B2, B3, 나이아민, 판토텐산, 비타민 E, 칼슘, 인, 리놀산 등 체단백의 합성에 필요한 유효성분을 많이 함유하고 있어, 말초혈액순환을 좋게하고 동맥경화예방과 혈압조절에 도움을 주는 것으로 알려져 있다.The nutritional composition according to the present invention is characterized in that it is blended with brown rice in the composition for the improvement of palatability. Brown rice is stripped only from the outermost rice husks from harvested rice and contains many active ingredients necessary for the synthesis of body proteins such as vitamins B 1 , B 2 , B 3 , niamine, pantothenic acid, vitamin E, calcium, phosphorus and linoleic acid. It is known to improve peripheral blood circulation and help prevent arteriosclerosis and blood pressure control.
본 발명에서 사용하는 현미분말은 공지의 방법으로 제조한 것을 사용해도 무방하나, 6~12시간 물에 침지시킨 후 건져내어 120℃에서 1분간 증숙한 후, 건조시켜 100~150℃에서 30분~1시간 로스팅시킨 것을 사용하는 경우 기호성을 더욱 증가시킬 수 있다. 본 발명의 조성물에서 현미는 0.5~10중량%의 양으로 배합되는 것이 바람직하다. 0.5중량% 미만일 경우 첨가효과가 떨어지고, 10중량%를 초과할 경우 현미 특유의 고소함이 지나쳐 오히려 기호성이 떨어진다.The brown rice powder used in the present invention may be prepared by a known method, but it is immersed in water for 6 to 12 hours, then scooped out and steamed for 1 minute at 120 ° C., then dried and dried at 100 to 150 ° C. for 30 minutes to If you use a one-hour roast, you can increase the palatability. In the composition of the present invention, the brown rice is preferably blended in an amount of 0.5 to 10% by weight. If the amount is less than 0.5% by weight, the effect of addition is lowered, and if it exceeds 10% by weight, the savory characteristic of brown rice is excessive and the palatability is lowered.
또한, 본 발명의 영양조성물은 다이어트시의 기초대사율의 유지를 위하여 옥타코사놀을 배합하는 것을 특징으로 한다. 대개의 다이어트에 있어서 체중감량에 따라 기초대사율도 급속하게 감소되는데, 감소된 기초대사율 만큼의 칼로리 여분이 지방으로 바뀌게 되어 오히려 체지방이 증가할 수도 있다. 따라서 다이어트시 기초대사율을 유지시켜 주는 것은 매우 중요하며, 본 발명에서는 이를 목적으로 옥타코사놀을 배합하고 있다. 옥타코사놀은 소맥의 잎, 사과의 표피 등에 극미량 함유되어 있는 천연 생리활성물질로 내구력의 증진, 반사, 순발력의 향상, 스트레스에 대한 저항력 향상, 기초대사율 향상 등의 작용이 있음이 알려져 있다. 본 발명에서 옥타코사놀은 0.05~10중량%의 양으로 배합되는 것이 바람직하다. 0.05중량% 미만일 경우에는 첨가효과가 없으며, 10중량%를 초과하여 사용할 경우에는 기호성이 떨어진다.In addition, the nutritional composition of the present invention is characterized by blending octacosanol in order to maintain the basic metabolic rate during diet. In most diets, the basis metabolic rate decreases rapidly with weight loss, and the extra calories of the reduced basic metabolic rate are converted to fat, which may increase body fat. Therefore, it is very important to maintain the basic metabolic rate in the diet, the present invention is formulated with octacosanol for this purpose. It is known that octacosanol is a natural physiologically active substance contained in traces of wheat, apple skin, etc. and has an effect of improving durability, reflexes, quickness, resistance to stress, and metabolic rate. In the present invention, octacosanol is preferably blended in an amount of 0.05 to 10% by weight. If it is less than 0.05% by weight, there is no additive effect, and when used in excess of 10% by weight, the palatability is poor.
또한 본 발명에서는 이들외에도 당근분말, 오이분말, 셀러리분말, 파셀리분말 및 쑥분말등의 야채분말을 첨가하여 제조할 수 있고, 비타민류의 경우도 양을 증감할 수 있다.In addition, the present invention can be prepared by adding vegetable powders such as carrot powder, cucumber powder, celery powder, parsley powder and mugwort powder, and in the case of vitamins, the amount can be increased or decreased.
[시험예 1]관능검사Test Example 1 Sensory Test
[시험제품]관능검사에는 하기 표 1의 5가지 영양조성물을 제조하여 비교하였다.[Test Product] Sensory test was prepared by comparing the five nutritional compositions of Table 1 below.
전문 관능검사요원 10명을 대상으로 하여 실시예, 비교예의 다이어트 영양조성물에 대하여 맛, 향, 전반적인 기호도를 다음의 평가기준으로 점수화하였다. 평가는 3회에 걸쳐 반복 실시하였으며, 그 평균값을 표 2에 나타내었다.The taste, aroma, and overall acceptability of the diet nutritional compositions of Examples and Comparative Examples were scored by the following evaluation criteria. Evaluation was repeated three times, and the average value is shown in Table 2.
[평가기준]5 : 아주 좋음4 : 좋음[Evaluation criteria] 5: Very good 4: Good
3 : 보통2 : 나쁨3: Normal 2: Bad
1 : 아주 나쁨1: very bad
상기 표 2의 결과로부터, 현미분말을 첨가한 다이어트 영양조성물은 현미분말을 첨가하지 않은 영양조성물 1에 비해 현미 고유의 고소한 향과 맛 때문에 전체적으로 향미가 우수하며, 이때 현미분말의 첨가량이 10중량%를 초과한 영양조성물 2의 경우 현미의 구수한 맛이 지나쳐 오히려 전체적인 향미가 불량해지는 것을 알수 있다.From the results of Table 2, the diet nutritional composition to which brown rice powder is added has an excellent overall flavor due to the inherent flavor and taste of brown rice compared to the nutritional composition 1 to which brown rice powder is not added. In the case of nutritional composition exceeding 2, the delicious taste of brown rice is excessive, rather, the overall flavor is poor.
[시험예 2]임상실험Test Example 2 Clinical Experiment
[임상실험 대상자]비만도(표준체중을 (신장 - 100)× 0.9 의 식으로 계산한 후 표준체중의 초과량을 계산)가 120~150%인 19~40세 사이의 사회활동을 하는 여성을 선정하였다. 이들의 신장은 150~173㎝였다. 대상자들을 5개 그룹으로 나누어, 1그룹당 7명씩 나누었다. 그룹을 나눌때는 대상자들과 면담을 통해 체질과 비만도 등이 고루 분포되도록 하였다.[Clinical trial subjects] Selected women who are socially active between the ages of 19 and 40 with obesity (120-150% calculated after calculating the standard weight as (height-100) × 0.9). It was. Their height was 150-173 cm. The subjects were divided into five groups, seven per group. When dividing the group, the subjects were interviewed to distribute the constitution and obesity evenly.
[시험제품]관능검사에는 하기 표 3의 5가지 영양조성물을 제조하여 비교하였다.[Test Product] Sensory test was prepared by comparing the five nutritional compositions of Table 3 below.
[시험방법]대상자들에게 각각의 영양조성물을 나누어 주어, 아침(오전 7:00~9:00 사이)과 저녁(오후 17:00~19:00 사이)에 영양조성물을 40g을 차가운 물에 마시기 적당한 정도로 풀어(보통 물 200~250㎖) 복용시켰으며, 점심(오후 12:00~14:00 사이)은 규정된 일반 식사(약 600㎉)를 섭취하도록 하였다. 이 기간동안 대상자들이 평소의 사회활동을 그대로 하도록 하였다. 또한 대상자들이 먹은 음식과 운동, 체중 등을 기록하게 하여 판단자료로 활용하였다.[Test method] Distribute each nutritional composition to the subjects and drink 40g of the nutritional composition in cold water in the morning (between 7:00 am and 9:00 am) and in the evening (between 17:00 and 19:00 pm). A moderate amount of loosening (usually 200-250 ml) was taken, and lunch (between 12:00 and 14:00 pm) was given a regular meal (approximately 600 ㎉). During this period, subjects were allowed to keep their usual social activities. In addition, the subjects recorded food, exercise, and weight that they ate and used as judgment data.
측정항목은 다음과 같으며, 임상실험을 하기 전, 그리고 3주 복용 후의 2회에 걸쳐 각 항목을 측정하였다.The measurement items were as follows. Each item was measured before the clinical trial and two times after taking 3 weeks.
측정항목 : 신장, 초기 체중, 3주후 체중, 체지방(Fat Body Weight : 피부의 밑 또는 내장주위에 있는 지방을 말하며 비만이라 함은, 이 체지방이 신체에 과다하게 존재함을 말한다), 기초대사율(Basal Metabolic Rate : 생명을 유지하는데 필요한 최소량의 에너지대사를 말한다), 혈액검사, 소변검사 등을 하였다.Measurement items: height, initial weight, body weight after 3 weeks, fat body (Fat Body Weight: Fat under skin or visceral area. Obesity means excessive body fat exists in the body), basic metabolic rate ( Basal Metabolic Rate: The minimum amount of energy metabolism needed to maintain life), blood test, urine test, etc.
혈액검사로는 총단백(Total Protein), BUN(Blood Urea Nitrogen), SGOT(Aspartic Aminotransferase), SGPT(Alanine Aminotransferase), γ-GTP(γ-Glutamyl Transpeptidase), 콜레스테롤(Cholesterol), 중성지방(Triglyceride), 고밀도콜레스테롤(HDL-Cholesterol), 저밀도콜레스테롤(LDL-Cholesterol), 칼륨, 칼슘, Hb A1c(Hemoglobin A1c), 헤모글로빈(Hemoglobin), 헤마토크리트(HCT, Hematocrit), 적혈구(RBC, Red Blood Cell), 백혈구(WBC, White Blood Cell), 혈소판(Platelet) 등을 측정하였다.Blood tests include Total Protein, Blood Urea Nitrogen (BUN), Aspartic Aminotransferase (SGOT), Alanine Aminotransferase (SGTG), γ-Glutamyl Transpeptidase (γ-GTP), Cholesterol, Triglyceride , High density cholesterol (HDL-Cholesterol), low density cholesterol (LDL-Cholesterol), potassium, calcium, Hb A1c (Hemoglobin A1c), hemoglobin (Hemoglobin), hematocrit (HBC, Hematocrit), red blood cells (RBC, Red Blood Cell) (WBC, White Blood Cell), Platelets and the like were measured.
소변검사로서는 색상(Color), 비중(S.P, Specific gravity), 알부민(Albumin), 포도당(Glucose), 케톤체(Keton Bodies), 빌리루빈(Bilirubin), 아질산염(Nitrite), 혈액(Blood), 우로빌리노겐(Urobilinogen), 적혈구(RBC), 백혈구(WBC), 상피세포(E.P Cells), 원주세포류(Casts), 세균(Bacteria), 결정체(Crystals) 등을 측정하였다.Urine tests include color, specific gravity (SP), albumin, albumin, glucose, ketone bodies, bilirubin, nitrite, blood, urobilinogen (Urobilinogen), red blood cells (RBC), white blood cells (WBC), epithelial cells (EP Cells), columnar cells (Casts), bacteria (Bacteria), crystals (Crystals) and the like were measured.
측정방법으로서 체지방, 기초대사율은 체지방측정기(BIODYNAMICS사, Biodynamics Model 310, Body Composition Analyzer)로 측정하였다.Body fat and basal metabolic rate were measured by a body fat analyzer (BIODYNAMICS, Biodynamics Model 310, Body Composition Analyzer).
혈액검사와 소변검사는 대상자들을 12시간 동안 금식시킨 후, 혈액과 소변을 채취하여 혈액종합검사(Blood complete profile test) 및 소변검사(Urinalysis)를 통하여 검사하였다.Blood test and urine test were fasted for 12 hours, and blood and urine samples were collected through blood complete profile test and urinalysis.
[시험결과] 임상시험 결과를 표 4에서 표 9까지 나타내었다. 이 결과들을 각각 살펴보면 다음과 같다.[Test Results] The clinical test results are shown in Table 4 to Table 9. Each of these results is as follows.
표 4에서 나타난 바와 같이, 체중감량이 가장 많이 된 것은 대두분리단백펩타이드분말을 배합한 7과 9이며, 그 다음으로는 가르시니아 캄보지아 추출물을 배합한 8과 10이 대조군에 비해 월등하게 체중감량이 많이 되었음을 알 수 있다.As shown in Table 4, the most weight loss was 7 and 9 containing soybean isolate peptide powder, followed by 8 and 10 containing garcinia cambogia extract. It can be seen that.
표 5에서 나타난 바와 같이, 체중감량 중에서도 체지방 감량이 많이 이루어진 것은 영양조성물 9이며, 그 다음으로는 영양조성물 7, 10, 8, 6의 순서로 체지방이 많이 감소됨을 알 수 있다.As shown in Table 5, among the weight loss, a lot of body fat loss is made of nutritional composition 9, and then it can be seen that body fat is greatly reduced in the order of nutritional composition 7, 10, 8, 6.
비만이라는 것은 체지방의 증가에 따른 것이므로, 결국 체지방을 감소시킴으로써 체중감량이 이루어져야 한다. 이런 점에서 보면, 영양조성물 6의 경우, 체중감량의 내용중 체지방의 감량이 차지하는 비율이 58.8%로, 체중감량의 나머지는 근육단백질 등의 제지방 감량이나 체수분량의 감량이 차지함을 알 수 있다. 제지방의 감량은 인체내의 단백질이 감량되는 것을 의미하므로, 이러한 제지방의 감량은 신체에 무리를 주게되어 신체기능에 이상을 초래할 우려가 많다. 반면, 대두분리단백펩타이드 분말이나 가르시니아 캄보지아 추출물을 배합한 영양조성물의 경우 체중감량은 주로 체지방 감량을 통해 이루어짐을 알 수 있다.Obesity is due to the increase in body fat, so you should eventually lose weight by reducing body fat. In this regard, in the case of the nutritional composition 6, the weight loss of body fat accounted for 58.8%, and the rest of weight loss accounted for lean body fat loss and body water loss, such as muscle protein. . Loss of lean body mass means that the protein in the human body is lost, and such loss of lean body mass causes a lot of problems in the body function. On the other hand, it can be seen that the weight loss is mainly achieved through body fat loss in the case of a nutrient composition containing soybean isolate protein powder or garcinia cambogia extract.
표 6에서 나타난 바와 같이, 영양조성물 7, 8의 경우 기초대사율이 적은 비율로 감소하였으며, 옥타코사놀을 배합한 영양조성물 9와 10의 경우 오히려 기초대사율이 증가하는 결과를 보여주고 있다. 반면 영양조성물 6의 경우 기초대사율이 많이 감소한 것으로 나타났다.As shown in Table 6, the basic metabolic rate of nutrient composition 7, 8 was reduced to a small rate, and the basic metabolic rate of nutrient composition 9 and 10 containing octacosanol was increased. On the other hand, in the case of nutrient composition 6, the basic metabolic rate decreased significantly.
다이어트를 할때 기초대사율은 변화가 없는 것이 좋다. 그 이유는 대개의 다이어트에 있어서 식사량을 감소시킴에 따라 체중은 어느 정도 감소될 수 있지만 아울러 기초대사율도 급속하게 감소됨을 볼 수 있다. 이때 식사량을 본래의 양으로 환원시키게 되면 기초대사율이 감소된 만큼의 칼로리 여분이 지방으로 바뀌게 된다. 이렇게 되면 오히려 다이어트를 하기 전보다 체중이 더 증가되는 요요현상이 발생하게 되므로, 결국은 다이어트의 의미가 없게 되는 것이다.When dieting, the basic metabolic rate should not change. The reason for this is that most diets reduce the amount of weight can be reduced to some extent, but also the basic metabolic rate can be seen to decrease rapidly. At this time, if the amount of the meal is reduced to the original amount, the amount of calories that are reduced as much as the basic metabolic rate is changed to fat. This will cause the yo-yo phenomenon that the weight is increased more than before the diet, it will not be the meaning of the diet eventually.
따라서, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어지도록 하는 것이 바람직하다. 이러한 점을 생각해 볼 때, 옥타코사놀을 배합한 영양조성물에서 기초대사율이 오히려 증가하는 결과가 나타나 다이어트에 매우 바람직함을 알 수 있다.Therefore, it is desirable to lose weight at a level where the basic metabolic rate does not fall during diet. Considering this point, the basic metabolic rate is increased in the nutritional composition containing octacosanol, it can be seen that the diet is very desirable.
표 7에서 나타난 바와 같이, 혈액검사 항목에서 각 영양조성물은 정상수준임을 나타냈다.As shown in Table 7, each nutrient composition in the blood test item was shown to be at a normal level.
표 8에서 나타난 바와 같이, 각 영양조성물은 소변검사 항목에서는 모두 정상을 나타내었다.As shown in Table 8, each nutrient composition was normal in the urine test items.
따라서, 이들 영양조성물이 모두 인체에 무리없는 안전한 다이어트임을 확인할 수 있다.Therefore, it can be confirmed that all of these nutritional compositions are safe and healthy diet to the human body.
지금까지의 여러 항목에 걸친 임상시험 결과를 볼때, 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄, 각종 비타민을 배합한 영양조성물에, 대두분리단백펩타이드분말이나 가르시니아 캄보지아 추출물, 옥타코사놀을 배합함으로써 체중감량, 체지방 감량, 기초대사율의 유지 등 다이어트 효과에 있어서 상승효과를 나타내었다.Based on the results of various clinical trials to date, soybean isolated protein peptide powder, garcinia cambogia extract, and octacosanol are combined with nutritional composition containing vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins. As a result, there was a synergistic effect on diet effects such as weight loss, body fat loss, and maintenance of basal metabolic rate.
체중감량에 있어서 단순한 체중감량 보다는 체지방 감소, 기초대사율의 유지, 각 신체부분의 정상유지 등이 중요한 점으로 볼때, 본 발명에서 밝혀낸 원료들을 배합한 영양조성물이 다이어트식으로서 이상적인 조성물이라고 판단된다.Considering the importance of reducing body fat, maintaining basic metabolic rate, and maintaining the normality of each body part in weight loss, it is judged that the nutritional composition containing the ingredients disclosed in the present invention is an ideal composition as a diet.
이하, 상기한 시험예의 결과를 근거로 하여, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어질 수 있으며, 체지방 감소에 있어서 상승효과를 제공할 수 있으면서, 맛과 향의 기호성이 우수한 여러 조성의 다이어트 영양조성물을 제시한다. 그러나 본 발명은 이들 실시예에만 한정되지는 않는다. 본 발명은 아래에 예시한 실시예이외에도 각 성분의 함량을 앞에서 제시한 범위내에서 자유롭게 증감시킬 수 있다. 또한 앞에서 예시한 여러 가지 영양성분을 첨가하여 제조할 수도 있다.Hereinafter, on the basis of the results of the above test examples, weight loss can be achieved at a level at which the basic metabolic rate does not fall during dieting, and can provide synergistic effects in reducing body fat, while having various taste and flavor preferences. Present diet nutritional composition. However, the present invention is not limited only to these examples. The present invention can freely increase or decrease the content of each component within the range set forth above in addition to the examples illustrated below. It can also be prepared by adding the various nutrients exemplified above.
(실시예 1)(Example 1)
대두단백 33중량%, 유단백 14.5중량%, 결정과당 22.398575중량%, 갈락토만난 12.5중량%, 글루코만난 3중량%, 올리고당 4중량%, 천연우유미네랄 4.25중량%, 현미분말 3중량%, 오이분말 2중량%, 대두분리단백펩타이드분말 1중량%, 옥타코사놀 0.1중량%, 비타민류 ; 비타민C 0.15중량%, 분말비타민E 0.05중량%, 니코틴산아미드 0.02중량%, 판토텐산칼슘 0.015중량%, 분말비타민A 0.01중량%, 비타민B6염산염 0.002중량%, 비타민B20.002중량%, 비타민B1염산염 0.0015중량%, 엽산 0.0003중량%, 비오틴 0.0001중량%, 햄철 0.0005중량%, 비타민D30.00002중량%, 비타민B120.000005중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 33%, milk protein 14.5%, fructose 22.398575%, galactomannan 12.5%, glucomannan 3%, oligosaccharides 4%, natural milk mineral 4.25%, brown rice powder 3%, cucumber powder 2 Weight%, soybean isolated protein peptide powder 1% by weight, octacosanol 0.1% by weight, vitamins; Vitamin C 0.15%, Powdered Vitamin E 0.05%, Nicotinamide 0.02%, Pantothenate Calcium 0.015%, Powdered Vitamin A 0.01%, Vitamin B 6 Hydrochloride 0.002%, Vitamin B 2 0.002%, Vitamin B 1 hydrochloride 0.0015% by weight, and of folic acid 0.0003% by weight, biotin 0.0001% by weight, into the haemcheol 0.0005% by weight of vitamin D 3 0.00002% by weight, vitamin B 12 0.000005% by weight to a high-speed rotary mixer was sufficiently mixed, and then, 40 ~ 50g per capsule Filled thickly.
(실시예 2)(Example 2)
대두단백 35중량%, 유단백 15중량%, 결정과당 20.577482중량%, 갈락토만난 11중량%, 글루코만난 2.5중량%, 차전자피 0.5중량%, 당근분말 3중량%, 올리고당 3중량%, 천연우유미네랄 3.27중량%, 현미분말 4.7중량%, 대두분리단백펩타이드분말 0.5중량%, 가르시니아 캄보지아 추출물 0.6중량%, 옥타코사놀 0.05중량%, 프로필렌글리콜지방산에스테르 0.002중량%, 덱스트린 0.008중량%, 비타민류 ; 비타민C 0.1375중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.0325중량%, 판토텐산칼슘 0.0205중량%, 분말비타민A 0.0091중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.0025중량%, 엽산 0.00114중량%, 비오틴 0.00057중량%, 햄철 0.0007중량%, 비타민D30.005중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 35 wt%, milk protein 15 wt%, fructose 20.577482 wt%, galactomannan 11 wt%, glucomannan 2.5 wt%, chaff bark 0.5 wt%, carrot powder 3 wt%, oligosaccharide 3 wt%, natural milk mineral 3.27 wt% %, Brown rice powder 4.7% by weight, soybean isolated protein peptide 0.5% by weight, garcinia cambogia extract 0.6% by weight, octacosanol 0.05% by weight, propylene glycol fatty acid ester 0.002% by weight, dextrin 0.008% by weight, vitamins; Vitamin C 0.1375%, Powdered Vitamin E 0.075%, Nicotinamide 0.0325%, Pantothenate Calcium 0.0205%, Powdered Vitamin A 0.0091%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.0025% hydrochloride, 0.00114% folic acid, 0.00057% biotin, 0.0007% ham iron, 0.0007% vitamin D 3 , and 0.00508% vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
(실시예 3)(Example 3)
대두단백 35중량%, 유단백 15중량%, 결정과당 19.900582중량%, 갈락토만난 10.5중량%, 글루코만난 3.5중량%, 차전자피 0.5중량%, 당근분말 2중량%, 오이분말 0.2중량%, 올리고당 3중량%, 천연우유미네랄 3.52중량%, 현미분말 5중량%, 가르시니아 캄보지아 추출물 1.5중량%, 옥타코사놀 0.07중량%, 비타민류 ; 비타민C 0.15중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.035중량%, 판토텐산칼슘 0.0205중량%, 분말비타민A 0.011중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.0025중량%, 엽산 0.00114중량%, 비오틴 0.00057중량%, 햄철 0.0007중량%, 비타민D30.005중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 35 wt%, milk protein 15 wt%, fructose 19.900582 wt%, galactomannan 10.5 wt%, glucomannan 3.5 wt%, chaff peel 0.5 wt%, carrot powder 2 wt%, cucumber powder 0.2 wt%, oligosaccharide 3 wt% Natural milk mineral 3.52 wt%, brown rice powder 5 wt%, garcinia cambogia extract 1.5 wt%, octacosanol 0.07 wt%, vitamins; Vitamin C 0.15%, Powdered Vitamin E 0.075%, Nicotinamide 0.035%, Pantothenate Calcium 0.0205%, Powdered Vitamin A 0.011%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.0025% hydrochloride, 0.00114% folic acid, 0.00057% biotin, 0.0007% ham iron, 0.0007% vitamin D 3 , and 0.00508% vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
(실시예 4)(Example 4)
대두단백 35중량%, 유단백 15중량%, 결정과당 20.577482중량%, 갈락토만난 11중량%, 글루코만난 2.5중량%, 차전자피 0.5중량%, 당근분말 3중량%, 올리고당 3중량%, 천연우유미네랄 3.27중량%, 현미분말 5.3중량%, 대두분리단백펩타이드분말 0.5중량%, 옥타코사놀 0.05중량%, 프로필렌글리콜지방산 에스테르 0.002중량%, 덱스트린 0.008중량%, 비타민류 ; 비타민C 0.1375중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.0325중량%, 판토텐산칼슘 0.0205중량%, 분말비타민A 0.0091중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.0025중량%, 엽산 0.00114중량%, 비오틴 0.00057중량%, 햄철 0.0007중량%, 비타민D30.005중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 35 wt%, milk protein 15 wt%, fructose 20.577482 wt%, galactomannan 11 wt%, glucomannan 2.5 wt%, chaff bark 0.5 wt%, carrot powder 3 wt%, oligosaccharide 3 wt%, natural milk mineral 3.27 wt% %, Brown rice powder 5.3% by weight, soybean isolated protein peptide powder 0.5% by weight, octacosanol 0.05% by weight, propylene glycol fatty acid ester 0.002% by weight, dextrin 0.008% by weight, vitamins; Vitamin C 0.1375%, Powdered Vitamin E 0.075%, Nicotinamide 0.0325%, Pantothenate Calcium 0.0205%, Powdered Vitamin A 0.0091%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.0025% hydrochloride, 0.00114% folic acid, 0.00057% biotin, 0.0007% ham iron, 0.0007% vitamin D 3 , and 0.00508% vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
(실시예 5)(Example 5)
대두단백 35중량%, 유단백 15중량%, 결정과당 20.577482중량%, 갈락토만난 11중량%, 글루코만난 2.5중량%, 차전자피 0.5중량%, 당근분말 3중량%, 올리고당 3중량%, 천연우유미네랄 3.27중량%, 현미분말 5중량%, 대두분리단백펩타이드분말 0.5중량%, 가르시니아 캄보지아 추출물 0.3중량%, 옥타코사놀 0.05중량%, 프로필렌글리콜지방산 에스테르 0.002중량%, 덱스트린 0.008중량%, 비타민류 ; 비타민C 0.1375중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.0325중량%, 판토텐산칼슘 0.0205중량%, 분말비타민A 0.0091중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.0025중량%, 엽산 0.00114중량%, 비오틴 0.00057중량%, 햄철 0.0007중량%, 비타민D30.005중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 35 wt%, milk protein 15 wt%, fructose 20.577482 wt%, galactomannan 11 wt%, glucomannan 2.5 wt%, chaff bark 0.5 wt%, carrot powder 3 wt%, oligosaccharide 3 wt%, natural milk mineral 3.27 wt% %, Brown rice powder 5% by weight, soybean isolated protein peptide 0.5% by weight, garcinia cambogia extract 0.3% by weight, octacosanol 0.05% by weight, propylene glycol fatty acid ester 0.002% by weight, dextrin 0.008% by weight, vitamins; Vitamin C 0.1375%, Powdered Vitamin E 0.075%, Nicotinamide 0.0325%, Pantothenate Calcium 0.0205%, Powdered Vitamin A 0.0091%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.0025% hydrochloride, 0.00114% folic acid, 0.00057% biotin, 0.0007% ham iron, 0.0007% vitamin D 3 , and 0.00508% vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
(실시예 6)(Example 6)
대두단백 33중량%, 유단백 19중량%, 결정과당 20.012782중량%, 갈락토만난 10중량%, 글루코만난 2.5중량%, 차전자피 0.5중량%, 당근분말 1중량%, 쑥분말 2중량%, 올리고당 3중량%, 천연우유미네랄 3.27중량%, 현미분말 1중량%, 대두분리단백펩타이드분말 1.5중량%, 가르시니아 캄보지아 추출물 0.8중량%, 옥타코사놀 0.1중량%, 프로필렌글리콜지방산 에스테르 0.002중량%, 덱스트린 2.008중량%, 비타민류 ; 비타민C 0.15중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.035중량%, 판토텐산칼슘 0.0205중량%, 분말비타민A 0.01중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.0025중량%, 엽산 0.00114중량%, 비오틴 0.00057중량%, 햄철 0.001중량%, 비타민D30.0035중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 33 wt%, milk protein 19 wt%, fructose 20.012782 wt%, galactomannan 10 wt%, glucomannan 2.5 wt%, chaff bark 0.5 wt%, carrot powder 1 wt%, mugwort powder 2 wt%, oligosaccharide 3 wt% , Natural milk mineral 3.27% by weight, brown rice powder 1%, soybean isolated protein peptide 1.5% by weight, garcinia cambogia extract 0.8% by weight, octacosanol 0.1% by weight, propylene glycol fatty acid ester 0.002% by weight, dextrin 2.008% by weight, vitamins ; Vitamin C 0.15%, Powdered Vitamin E 0.075%, Nicotinamide 0.035%, Pantothenate Calcium 0.0205%, Powdered Vitamin A 0.01%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.0025% hydrochloride, 0.00114% folic acid, 0.00057% biotin, 0.001% ham iron, 0.0035% vitamin D 3 , and 0.003508% vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
(실시예 7)(Example 7)
대두단백 33중량%, 유단백 17중량%, 결정과당 20.333475중량%, 갈락토만난 10.5중량%, 글루코만난 2.5중량%, 당근분말 2중량%, 셀러리분말 0.5중량%, 올리고당 2.5중량%, 천연우유미네랄 4중량%, 현미분말 5중량%, 대두분리단백펩타이드분말 1중량%, 가르시니아 캄보지아 추출물 1.3중량%, 옥타코사놀 0.08중량%, 비타민류 ; 비타민C 0.17중량%, 분말비타민E 0.05중량%, 니코틴산아미드 0.03중량%, 판토텐산칼슘 0.02중량%, 분말비타민A 0.01중량%, 비타민B6염산염 0.002중량%, 비타민B20.002중량%, 비타민B1염산염 0.0015중량%, 엽산 0.0003중량%, 비오틴 0.0001중량%, 햄철 0.0006중량%, 비타민D30.00002중량%, 비타민B120.000005중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 33 wt%, milk protein 17 wt%, fructose 20.333475 wt%, galactomannan 10.5 wt%, glucomannan 2.5 wt%, carrot powder 2 wt%, celery powder 0.5 wt%, oligosaccharide 2.5 wt%, natural milk mineral 4 Weight%, brown rice powder 5% by weight, soybean isolated protein peptide powder 1% by weight, 1.3% by weight Garcinia cambogia extract, 0.08% by weight octacosanol, vitamins; Vitamin C 0.17%, Powdered Vitamin E 0.05%, Nicotinamide 0.03%, Pantothenate Calcium 0.02%, Powdered Vitamin A 0.01%, Vitamin B 6 Hydrochloride 0.002%, Vitamin B 2 0.002%, Vitamin B 1 hydrochloride 0.0015% by weight, and of folic acid 0.0003% by weight, biotin 0.0001% by weight, into the haemcheol 0.0006% by weight of vitamin D 3 0.00002% by weight, vitamin B 12 0.000005% by weight to a high-speed rotary mixer was sufficiently mixed, and then, 40 ~ 50g per capsule Filled thickly.
(실시예 8)(Example 8)
대두단백 34중량%, 유단백 14중량%, 결정과당 21.887482중량%, 갈락토만난 11중량%, 글루코만난 2.5중량%, 차전자피 0.5중량%, 당근분말 3중량%, 오이분말 1중량%, 쑥분말 2중량%, 올리고당 1.5중량%, 천연우유미네랄 3.27중량%, 현미분말 2중량%, 대두분리단백펩타이드분말 1중량%, 옥타코사놀 0.05중량%, 덱스트린 2중량%, 비타민류 ; 비타민C 0.1375중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.0325중량%, 판토텐산칼슘 0.0205중량%, 분말비타민A 0.0091중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.0025중량%, 엽산 0.00114중량%, 비오틴 0.00057중량%, 햄철 0.0007중량%, 비타민D30.005중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 34 wt%, milk protein 14 wt%, fructose 21.887482 wt%, galactomannan 11 wt%, glucomannan 2.5 wt%, chaff peel 0.5 wt%, carrot powder 3 wt%, cucumber powder 1 wt%, mugwort powder 2 wt% %, Oligosaccharide 1.5% by weight, natural milk mineral 3.27% by weight, brown rice powder 2% by weight, soybean isolated protein peptide powder 1% by weight, octacosanol 0.05% by weight, dextrin 2% by weight, vitamins; Vitamin C 0.1375%, Powdered Vitamin E 0.075%, Nicotinamide 0.0325%, Pantothenate Calcium 0.0205%, Powdered Vitamin A 0.0091%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.0025% hydrochloride, 0.00114% folic acid, 0.00057% biotin, 0.0007% ham iron, 0.0007% vitamin D 3 , and 0.00508% vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
(실시예 9)(Example 9)
대두단백 28중량%, 유단백 21중량%, 결정과당 19.539992중량%, 갈락토만난 10중량%, 글루코만난 2.15중량%, 차전자피 0.5중량%, 쑥분말 3중량%, 올리고당 2중량%, 천연우유미네랄 4.3중량%, 현미분말 5중량%, 대두분리단백펩타이드분말 1.5중량%, 가르시니아 캄보지아 추출물 0.5중량%, 옥타코사놀 0.15중량%, 덱스트린 2중량%, 비타민류 ; 비타민C 0.175중량%, 분말비타민E 0.0975중량%, 니코틴산아미드 0.035중량%, 판토텐산칼슘 0.025중량%, 분말비타민A 0.01중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.005중량%, 엽산 0.0014중량%, 비오틴 0.0007중량%, 햄철 0.0009중량%, 비타민D30.0015중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.28% soy protein, 21% milk protein, 19.539992% fructose, 10% galactomannan, 2.15% glucomannan, 0.5% charcoal bark, 3% wormwood powder, 2% oligosaccharide, 4.3% natural milk mineral %, Brown rice powder 5% by weight, soybean isolated protein peptide 1.5% by weight, 0.5% by weight Garcinia cambogia extract, 0.15% by weight octacosanol, 2% by weight dextrin, vitamins; Vitamin C 0.175%, Powdered Vitamin E 0.0975%, Nicotinamide 0.035%, Pantothenate Calcium 0.025%, Powdered Vitamin A 0.01%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.005% by weight of hydrochloride, 0.0014% by weight folic acid, 0.0007% by weight biotin, 0.0009% by weight ham ham, 0.0015% by weight vitamin D 3 and 0.000008% by weight vitamin B 12 are mixed in a high-speed rotary mixer, and then mixed 40-50 g in one bag. Filled thickly.
(실시예 10)(Example 10)
대두단백 34중량%, 유단백 13중량%, 결정과당 20.032592중량%, 갈락토만난 11중량%, 글루코만난 2중량%, 당근분말 2중량%, 셀러리분말 1중량%, 파셀리분말 0.5중량%, 쑥분말 2중량%, 올리고당 3중량%, 천연우유미네랄 3.27중량%, 현미분말 5중량%, 대두분리단백펩타이드분말 0.5중량%, 가르시니아 캄보지아 추출물 0.3중량%, 옥타코사놀 0.05중량%, 프로필렌글리콜지방산에스테르 0.002중량%, 덱스트린 2.008중량%, 비타민류 ; 비타민C 0.175중량%, 분말비타민E 0.075중량%, 니코틴산아미드 0.0325중량%, 판토텐산칼슘 0.025중량%, 분말비타민A 0.009중량%, 비타민B6염산염 0.005중량%, 비타민B20.003중량%, 비타민B1염산염 0.005중량%, 엽산 0.0014중량%, 비오틴 0.0007중량%, 햄철 0.0008중량%, 비타민D30.005중량%, 비타민B120.000008중량%를 고속회전혼합기에 넣고 충분히 혼합시킨 다음, 1포에 40~50g씩 충진하였다.Soy protein 34%, milk protein 13%, fructose 20.032592%, galactomannan 11%, glucomannan 2%, carrot powder 2%, celery powder 1%, parsley powder 0.5%, mugwort powder 2 Weight%, oligosaccharide 3%, natural milk mineral 3.27%, brown rice powder 5%, soybean isolated protein peptide 0.5% by weight, garcinia cambogia extract 0.3% by weight, octacosanol 0.05% by weight, propylene glycol fatty acid ester 0.002% by weight, Dextrin 2.008 wt%, vitamins; Vitamin C 0.175%, Powdered Vitamin E 0.075%, Nicotinamide 0.0325%, Pantothenate Calcium 0.025%, Powdered Vitamin A 0.009%, Vitamin B 6 Hydrochloride 0.005%, Vitamin B 2 0.003%, Vitamin B 1 0.005% by weight of hydrochloride, 0.0014% by weight folic acid, 0.0007% by weight biotin, 0.0008% by weight ham ham, 0.005% by weight vitamin D 3 , and 0.000008% by weight vitamin B 12 were mixed in a high-speed rotary mixer and mixed well. Filled thickly.
본 발명에 따른 다이어트 영양조성물은, 식물성 단백, 동물성 단백, 식이섬유, 올리고당, 천연 우유미네랄 및 각종 비타민을 배합한 영양조성물에, 대두분리단백펩타이드 또는 가르시니아 캄보지아 추출물 중에서 1종 이상과, 현미 및 옥타코사놀을 배합하여 이루어진 것으로, 다이어트시 기초대사율이 떨어지지 않는 수준에서 체중감량이 이루어질 수 있으며, 체지방 감소에 있어서 상승효과를 제공할 수 있으면서 맛과 향의 기호성이 우수하다.Dietary nutritional composition according to the present invention, at least one of soybean isolate protein peptide or garcinia cambogia extract, and brown rice and octacosanol to a nutritional composition containing vegetable protein, animal protein, dietary fiber, oligosaccharide, natural milk mineral and various vitamins It is made by combining, the weight loss can be made at a level that does not fall the basic metabolic rate in the diet, it can provide a synergistic effect in reducing body fat and excellent taste and flavor.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960044612A KR0180453B1 (en) | 1996-10-08 | 1996-10-08 | Composition for diet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960044612A KR0180453B1 (en) | 1996-10-08 | 1996-10-08 | Composition for diet |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19980026245A true KR19980026245A (en) | 1998-07-15 |
KR0180453B1 KR0180453B1 (en) | 1999-10-01 |
Family
ID=19476646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960044612A KR0180453B1 (en) | 1996-10-08 | 1996-10-08 | Composition for diet |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0180453B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101332920B1 (en) * | 2012-02-24 | 2013-12-02 | 웅진식품주식회사 | Bevearage composition for regulating body weight and alternative mill, and preparation method for the same |
KR20220111096A (en) * | 2021-02-01 | 2022-08-09 | (주)에이티바이오 | Functional feed composition containing creatine and octacosanol |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020071152A (en) * | 2001-03-05 | 2002-09-12 | 정풍한방제약주식회사 | Functional food composition and a process thereof |
KR100503208B1 (en) * | 2002-10-05 | 2005-07-21 | 주식회사 한국메디 | Diet-food composition |
KR101366177B1 (en) * | 2012-03-23 | 2014-02-24 | 이은혜 | Composition comprising dietary fiber |
KR101440465B1 (en) * | 2013-01-25 | 2014-09-17 | 재단법인 진안홍삼연구소 | Ginseng diet shake |
KR101456415B1 (en) * | 2014-04-16 | 2014-10-31 | (주)엠피위즈 | The method of manufacturing bar-shaped functional food for diet |
CN105124592A (en) * | 2015-10-08 | 2015-12-09 | 杭州悠购网络科技有限公司 | All-nutrition rapid staple food grain and preparing method thereof |
-
1996
- 1996-10-08 KR KR1019960044612A patent/KR0180453B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101332920B1 (en) * | 2012-02-24 | 2013-12-02 | 웅진식품주식회사 | Bevearage composition for regulating body weight and alternative mill, and preparation method for the same |
KR20220111096A (en) * | 2021-02-01 | 2022-08-09 | (주)에이티바이오 | Functional feed composition containing creatine and octacosanol |
Also Published As
Publication number | Publication date |
---|---|
KR0180453B1 (en) | 1999-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102106498B (en) | Weight losing meal-replacing powder | |
CN109329907A (en) | A kind of nutritional meal replacement powder and preparation method thereof | |
KR102396152B1 (en) | Easy-to-eat of Nutrition Balance Health Food | |
KR100448260B1 (en) | Processing Methods of Health Food for the Control of Body Weight | |
CN104247734A (en) | Mulberry leaf pineapple cake and making method thereof | |
CN103844249A (en) | Nutritional food, and preparation method thereof | |
CN106942585A (en) | One kind relaxes bowel ground rice and preparation method thereof | |
JP2016047037A (en) | Health food | |
KR0180453B1 (en) | Composition for diet | |
KR0182396B1 (en) | Nutrients for a diet | |
KR20030053094A (en) | The process of making Korean herb medicine kimchi for costitutional group | |
KR20210035600A (en) | galeusinia kambojialeul iyonghan daieoteusigpum jejobangbeob | |
KR100278206B1 (en) | Health supplement composition for growth | |
CN103141897A (en) | Preparation method of health-maintenance yam beverage | |
KR102324480B1 (en) | Health food containing Angelica Utilis Makino | |
CN104041553B (en) | The edible nutritive health biscuit of a kind of applicable the elderly | |
KR100390095B1 (en) | Preparation method of gimchi with aloe gel | |
CN106256237A (en) | Sweet-scented cake | |
KR20050045666A (en) | Composition for inhibiting of obesity | |
CN111296827A (en) | Composition and application thereof | |
CN110638057A (en) | Weight-losing meal replacement powder and preparation method thereof | |
KR20020071152A (en) | Functional food composition and a process thereof | |
RU2579215C1 (en) | Dry mixture for beverage preparation | |
Rusoff | Calcium–osteoporosis and blood pressure | |
CN1290418C (en) | Protein complementation powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20041102 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |